Hamps Bio Limited (BOM:544312)
25.85
0.00 (0.00%)
At close: Jun 15, 2026
Hamps Bio Revenue
In the fiscal year ending March 31, 2026, Hamps Bio had annual revenue of 88.07M INR with 32.06% growth. Hamps Bio had revenue of 39.92M in the half year ending September 30, 2025.
Revenue
88.07M
Revenue Growth
+32.06%
P/S Ratio
2.56
Revenue / Employee
1.17M
Employees
75
Market Cap
225.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 88.07M | 21.38M | 32.06% |
| Mar 31, 2025 | 66.69M | 1.94M | 2.99% |
| Mar 31, 2024 | 64.75M | 8.97M | 16.08% |
| Mar 31, 2023 | 55.78M | 2.38M | 4.45% |
| Mar 31, 2022 | 53.40M | 15.18M | 39.71% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.55B |
| JFL Life Sciences | 1.31B |
| Deccan Health Care | 819.05M |
| Walpar Nutritions | 757.46M |
| Panjon | 476.21M |
| Gujarat Terce Laboratories | 474.73M |
| Cian Healthcare | 232.80M |
| Zenith Healthcare | 105.22M |